Rani Therapeutics Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 884.61 K | $442.31 K | 10.62% | 2.42% |
| NAN FUNG GROUP HOLDINGS LTD | 11/13/2025 | 493.58 K | $246.69 K | 0.00% | 1.35% |
| CITADEL ADVISORS LLC | 11/14/2025 | 452.54 K | $226.18 K | 229.48% | 1.24% |
| UNITED SERVICES AUTOMOBILE ASSOCIATION | 11/14/2025 | 302.74 K | $151.31 K | 0.00% | 0.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 296.91 K | $148.41 K | 55.81% | 0.81% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 11/17/2025 | 226.14 K | $113.03 K | 44.83% | 0.62% |
| TAKEDA PHARMACEUTICAL CO LTD | 11/13/2025 | 203.19 K | $101.55 K | 0.00% | 0.56% |
| CWA ASSET MANAGEMENT GROUP, LLC | 10/22/2025 | 150.00 K | $74.97 K | 80.00% | 0.41% |
| BLACKROCK, INC. | 11/12/2025 | 120.23 K | $60.09 K | 1.33% | 0.33% |
| HRT FINANCIAL LP | 11/14/2025 | 113.21 K | $56.00 K | 100.00% | 0.31% |
| NORTHERN TRUST CORP | 11/14/2025 | 97.01 K | $48.48 K | -5.74% | 0.27% |
| UBS GROUP AG | 11/13/2025 | 69.12 K | $34.56 K | 11.37% | 0.19% |
| LASRY MARC | 11/14/2025 | 62.89 K | $31.43 K | 0.00% | 0.17% |
| STATE STREET CORP | 11/14/2025 | 62.44 K | $31.21 K | 0.00% | 0.17% |
| KING LUTHER CAPITAL MANAGEMENT CORP | 11/07/2025 | 58.00 K | $28.99 K | 0.00% | 0.16% |
| WELL DONE, LLC | 10/28/2025 | 52.01 K | $26.00 K | 0.00% | 0.14% |
| JANNEY MONTGOMERY SCOTT LLC | 10/27/2025 | 49.20 K | $25.00 K | -10.87% | 0.13% |
| MOTCO | 10/22/2025 | 48.13 K | $24.06 K | 0.00% | 0.13% |
| INSIGNEO ADVISORY SERVICES, LLC | 11/12/2025 | 47.50 K | $23.74 K | 0.00% | 0.13% |
| XTX TOPCO LTD | 11/14/2025 | 44.08 K | $22.03 K | 100.00% | 0.12% |
| BROWN ADVISORY INC | 11/14/2025 | 32.91 K | $16.45 K | 0.00% | 0.09% |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | 11/05/2025 | 27.21 K | $13.60 K | 0.00% | 0.07% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 24.91 K | $12.45 K | 100.00% | 0.07% |
| LAFAYETTE INVESTMENTS, INC. | 11/06/2025 | 19.89 K | $9.94 K | 0.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 17.75 K | $8.86 K | -43.04% | 0.05% |
| ACT ADVISORS, LLC. | 10/09/2025 | 14.81 K | $7.40 K | 100.00% | 0.04% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 12.63 K | $6.31 K | 31.31% | 0.03% |
| CHOREO, LLC | 11/12/2025 | 11.81 K | $5.90 K | 0.00% | 0.03% |
| CERITY PARTNERS LLC | 10/22/2025 | 10.00 K | $5.00 K | 0.00% | 0.03% |
| ISLAY CAPITAL MANAGEMENT, LLC | 11/12/2025 | 9.61 K | $4.80 K | 0.00% | 0.03% |
| MORGAN STANLEY | 11/14/2025 | 6.75 K | $3.37 K | -3.85% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 6.22 K | $3.11 K | -32.97% | 0.02% |
| ALLWORTH FINANCIAL LP | 12/02/2025 | 3.12 K | $1.56 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.00 K | $490 | -85.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 980 | $490 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 71 | $35 | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 10/31/2025 | 0 | $0 | -100.00% | 0.00% |
| AMERITAS ADVISORY SERVICES, LLC | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
Rani Therapeutics Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Rani Therapeutics Holdings, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 884,609
Nan Fung Group Holdings Ltd: 493,584
CITADEL ADVISORS LLC: 452,542
UNITED SERVICES AUTOMOBILE ASSOCIATION: 302,743
GEODE CAPITAL MANAGEMENT, LLC: 296,910
KESTRA PRIVATE WEALTH SERVICES, LLC: 226,142
11.04% of Rani Therapeutics Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.16 M shares in the last 24 months. This purchase volume represents approximately $6.61 M in transactions.